References
- 1 Kang TW, Yevsa T, Woller N et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature479(7374),547–551 (2011).
- 2 Serrano M. Cancer: final act of senescence. Nature479(7374),481–482 (2011).
- 3 Greer EL, Maures TJ, Ucar D et al. Transgenerational epigenetic inheritance of longevity in Caenorhabditis elegans. Nature479(7373),365–371 (2011).
- 4 Kim EB, Fang X, Fushan AA et al. Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature479(7372),223–227 (2011).
- 5 Baker DJ, Wijshake T, Tchkonia T et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature479(7372),232–236 (2011).
- 6 Danchin É, Charmantier A, Champagne FA, Mesoudi A, Pujol B, Blanchet S. Beyond DNA: integrating inclusive inheritance into an extended theory of evolution. Nat. Rev. Genet.12(7),475–486 (2011).
- 7 modENCODE Consortium; Roy S, Ernst J, Kharchenko PV et al. Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science330(6012),1787–1797 (2010).
- 8 Baylin SB, Jones PA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer.11(10),726–734 (2011).
- 9 Green ED, Guyer MS. National human genome research institute. Charting a course for genomic medicine from base pairs to bedside. Nature470(7333),204–213 (2011).
- 10 Roychowdhury S, Iyer MK, Robinson DR et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med.3(111),111ra121 (2011).
- 11 Ku CS, Naidoo N, Wu M, Soong R. Studying the epigenome using next generation sequencing. J. Med. Genet.48(11),721–730 (2011).
- 12 Cutillas PR, Jørgensen C. Biological signalling activity measurements using mass spectrometry. Biochem. J.434(2),189–199 (2011).
- 13 Cox J, Mann M. Quantitative, high-resolution proteomics for data-driven systems biology. Annu. Rev. Biochem.80,273–299 (2011).
- 14 Kosako H, Nagano K. Quantitative phosphoproteomics strategies for understanding protein kinase-mediated signal transduction pathways. Expert Rev. Proteomics8(1),81–94 (2011).
- 15 Schubert C. Single-cell analysis: the deepest differences. Nature480(7375),133–137 (2011).
- 16 Welch CM, Elliott H, Danuser G, Hahn KM. Imaging the coordination of multiple signalling activities in living cells. Nat. Rev. Mol. Cell Biol.12(11),749–756 (2011).
- 17 Cheong R, Rhee A, Wang CJ, Nemenman I, Levchenko A. Information transduction capacity of noisy biochemical signaling networks. Science334(6054),354–358 (2011).
- 18 Narod SA, Salmena L. BRCA1 and BRCA2 mutations and breast cancer. Discov. Med.12(66),445–453 (2011).
- 19 Petronis A. Epigenetics as a unifying principle in the aetiology of complex traits and diseases. Nature465(7299),721–727 (2010).
- 20 Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat. Rev. Genet.12(8),529–541 (2011).
- 21 Portela A, Esteller M. Epigenetic modifications and human disease. Nat. Biotechnol.28,1057–1068 (2010).
- 22 Baylin SB, Jones PA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer11(10),726–734 (2011).
- 23 Beltrao P, Cagney G, Krogan N. Quantitative genetic interactions reveal biological modularity. Cell141(5),739–745 (2010).
- 24 Gogol-Döring A, Chen W. An overview of the analysis of next generation sequencing data. Methods Mol. Biol.802,249–257 (2012).
- 25 Blaxter M. Genetics. Revealing the dark matter of the genome. Science330(6012),1758–1759 (2010).
- 26 Loscalzo J, Barabasi AL. Systems biology and the future of medicine. Wiley Interdiscip. Rev. Syst. Biol. Med.3(6),619–627 (2011).
- 27 Nandagopal N, Elowitz MB. Synthetic biology: integrated gene circuits. Science333(6047),1244–1248 (2011).
- 28 Weber W, Fussenegger M. Emerging biomedical applications of synthetic biology. Nat. Rev. Genet.13(1),21–35 (2011).
- 29 Fernández A, Lynch M. Non-adaptive origins of interactome complexity. Nature474(7352),502–505 (2011).